Q3 2025
Released Nov 19, 2025, before the open
10-Q filed Nov 19, 2025, 50 days after period end · 0000868278-25-000017
Q3 2025 · 10-Q
Revenue$883.00K$883.00K −37.6% vs Q3 2024−29.2% vs Q2 2025
Net Income-$6.84M-$6.84M N/M vs Q3 2024N/M vs Q2 2025
EPS Diluted-$0.16-$0.16 N/M vs Q3 2024N/M vs Q2 2025
Gross Profit-$123,000N/M
Operating Income-$4,764,000N/M
Operating Cash Flowderived-$3,486,000N/M
Free Cash Flowderived-$3,486,000N/M
Margins · derived
Gross margin-13.9%−29.1 pt vs Q3 2024
Operating margin-539.5%−81.9 pt vs Q3 2024
Net margin-774.5%−309.3 pt vs Q3 2024
What the release said
The release
Same quarter
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $883.00K | $1.42M | $8.37M | $24.20M |
| Net Income | -$6.84M | -$6.59M | -$5.14M | $968.00K |
| EPS Diluted | -$0.16 | -$0.35 | -$0.30 | $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR